MediciNova Announces Plans to Collaborate with UCLA Researchers in Grant-Funded Clinical Trial of MN-166 in Alcohol Use Disorder and Withdrawal Pharmaceutical Investing
Forward Pharma Appeals the Decision of the Opposition Division to Revoke the EP2801355 Patent Pharmaceutical Investing
Ultragenyx Reports First Quarter 2018 Financial Results and Corporate Update Pharmaceutical Investing
scPharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update Pharmaceutical Investing
Inspire Medical Systems Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Medical Device Investing
